161 related articles for article (PubMed ID: 22408922)
1. Hydrothermal synthesis of a highly sensitive T2-weigthed MRI contrast agent: zinc-doped superparamagnetic iron oxide nanocrystals.
Chen F; Bu W; Lu C; Chen G; Chen M; Shen X; Liu R; Shi J
J Nanosci Nanotechnol; 2011 Dec; 11(12):10438-43. PubMed ID: 22408922
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
Ma HL; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2007 Mar; 333(1-2):177-86. PubMed ID: 17074454
[TBL] [Abstract][Full Text] [Related]
3. Dextrin-coated zinc substituted cobalt-ferrite nanoparticles as an MRI contrast agent: In vitro and in vivo imaging studies.
Sattarahmady N; Zare T; Mehdizadeh AR; Azarpira N; Heidari M; Lotfi M; Heli H
Colloids Surf B Biointerfaces; 2015 May; 129():15-20. PubMed ID: 25819361
[TBL] [Abstract][Full Text] [Related]
4. A sub-50-nm monosized superparamagnetic Fe3O4@SiO2 T2-weighted MRI contrast agent: highly reproducible synthesis of uniform single-loaded core-shell nanostructures.
Chen F; Bu W; Chen Y; Fan Y; He Q; Zhu M; Liu X; Zhou L; Zhang S; Peng W; Shi J
Chem Asian J; 2009 Dec; 4(12):1809-1816. PubMed ID: 19902450
[TBL] [Abstract][Full Text] [Related]
5. MRI manifestation of novel superparamagnetic iron oxide nanoparticles in the rat inner ear.
Zou J; Zhang W; Poe D; Qin J; Fornara A; Zhang Y; Ramadan UA; Muhammed M; Pyykkö I
Nanomedicine (Lond); 2010 Jul; 5(5):739-54. PubMed ID: 20662645
[TBL] [Abstract][Full Text] [Related]
6. Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.
Chaudhary R; Roy K; Kanwar RK; Walder K; Kanwar JR
J Nanobiotechnology; 2016 Jan; 14():6. PubMed ID: 26775253
[TBL] [Abstract][Full Text] [Related]
7. Silica-Coated Nonstoichiometric Nano Zn-Ferrites for Magnetic Resonance Imaging and Hyperthermia Treatment.
Starsich FH; Sotiriou GA; Wurnig MC; Eberhardt C; Hirt AM; Boss A; Pratsinis SE
Adv Healthc Mater; 2016 Oct; 5(20):2698-2706. PubMed ID: 27592719
[TBL] [Abstract][Full Text] [Related]
8. Hydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapy.
Yoon HY; Saravanakumar G; Heo R; Choi SH; Song IC; Han MH; Kim K; Park JH; Choi K; Kwon IC; Park K
J Control Release; 2012 Jun; 160(3):692-8. PubMed ID: 22543013
[TBL] [Abstract][Full Text] [Related]
9. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles.
Jang JT; Nah H; Lee JH; Moon SH; Kim MG; Cheon J
Angew Chem Int Ed Engl; 2009; 48(7):1234-8. PubMed ID: 19137514
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging of endothelial cells with vectorized iron oxide nanoparticles.
Abakumov MA; Goldt AE; Sokolsky-Papkov M; Zorkina YA; Baklaushev VP; Goodilin EA; Kabanov AV; Chekhonin VP
Bull Exp Biol Med; 2011 Oct; 151(6):726-30. PubMed ID: 22485218
[TBL] [Abstract][Full Text] [Related]
11. Surface functionalization of magnetic iron oxide nanoparticles for MRI applications - effect of anchoring group and ligand exchange protocol.
Smolensky ED; Park HY; Berquó TS; Pierre VC
Contrast Media Mol Imaging; 2011; 6(4):189-99. PubMed ID: 21861279
[TBL] [Abstract][Full Text] [Related]
12. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
Tähkä S; Laiho A; Kostiainen MA
Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
[TBL] [Abstract][Full Text] [Related]
13. An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.
Ereath Beeran A; Nazeer SS; Fernandez FB; Muvvala KS; Wunderlich W; Anil S; Vellappally S; Ramachandra Rao MS; John A; Jayasree RS; Varma PR
Phys Chem Chem Phys; 2015 Feb; 17(6):4609-19. PubMed ID: 25586703
[TBL] [Abstract][Full Text] [Related]
14. Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy.
Ma X; Gong A; Chen B; Zheng J; Chen T; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2015 Feb; 126():44-9. PubMed ID: 25543982
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging.
Li L; Gao F; Jiang W; Wu X; Cai Y; Tang J; Gao X; Gao F
Drug Deliv; 2016 Jun; 23(5):1726-33. PubMed ID: 25715808
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible and fluorescent superparamagnetic iron oxide nanoparticles with superior magnetic properties coated with charged polysaccharide derivatives.
Lachowicz D; Szpak A; Malek-Zietek KE; Kepczynski M; Muller RN; Laurent S; Nowakowska M; Zapotoczny S
Colloids Surf B Biointerfaces; 2017 Feb; 150():402-407. PubMed ID: 27842931
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of the L-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer.
Chen YC; Min CN; Wu HC; Lin CT; Hsieh WY
J Biomater Appl; 2013 Nov; 28(4):580-94. PubMed ID: 23174955
[TBL] [Abstract][Full Text] [Related]
18. Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly (dopamine) for magnetic field-targeting, highly sensitive MRI and photothermal cancer therapy.
Wu M; Zhang D; Zeng Y; Wu L; Liu X; Liu J
Nanotechnology; 2015 Mar; 26(11):115102. PubMed ID: 25721867
[TBL] [Abstract][Full Text] [Related]
19. RGD-conjugated iron oxide magnetic nanoparticles for magnetic resonance imaging contrast enhancement and hyperthermia.
Zheng SW; Huang M; Hong RY; Deng SM; Cheng LF; Gao B; Badami D
J Biomater Appl; 2014 Mar; 28(7):1051-9. PubMed ID: 23796630
[TBL] [Abstract][Full Text] [Related]
20. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
